Regulatory intelligence for US exporters

DOJ's FCPA Unit Probing Pfizer

DOJ’s Foreign Corrupt Practices Act Unit is investigating U.S. pharmaceutical company Pfizer for its activities in Mexico, the company disclosed in an SEC filing this month. Pfizer said the agency’s FCPA Unit sent an “informal request” in March “seeking documents…

Start A Trial
relating to our operations in Mexico.” The company is “producing records pursuant to this request.” The probe comes after Pfizer in 2012 reached an agreement with DOJ to resolve FCPA violation charges and as the company handles requests from the FPCA unit for activities in China and Russia, according to its SEC filing.